Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1855]

CPX-351 improves outcomes for refractory AML

Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA

$CPX-351 improves outcomes for refractory AML ( Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )$

First in-human trials of rovalpituzumab for SCLC

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA

First in-human trials of rovalpituzumab for SCLC ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA )

Surgery in stage 4 breast cancer increased survival

Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA

Surgery in stage 4 breast cancer increased survival ( Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA )

Trial shows exercise beneficial for patients undergoing chemotherapy

Dr Ian Kleckner - University of Rochester Medical Center, New York, USA

Trial shows exercise beneficial for patients undergoing chemotherapy ( Dr Ian Kleckner - University of Rochester Medical Center, New York, USA )

Elderly patients with glioblastoma live longer with chemoradiation using...

Prof James Perry - University of Toronto, Toronto, Canada

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide ( Prof James Perry - University of Toronto, Toronto, Canada )

Intraperitoneal chemotherapy slows ovarian cancer progression

Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada

Intraperitoneal chemotherapy slows ovarian cancer progression ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine...

Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma ( Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK )

Phase II study of intraperitoneal versus intravenous chemotherapy following...

Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada

Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )

Temozolomide after radiotherapy improves glioma survival

Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands

Temozolomide after radiotherapy improves glioma survival ( Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi

Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )

Direct activation of STING in the tumour microenvironment leads to potent and...

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )

More from ecancer